Sumario
Info SECLA
Inforevista
Editorial
Paso a Paso
Día a Día
Nuevas tecnologías
Rincón del Residente
Noticias
Cursos y Congresos
Cartas a Endosurgery
Revisiones Bibliográficas
Foro
Informe Encuesta
Videoteca
Indice de Artículos
VII Congreso SECLA Valencia
 

 


powered by FreeFind
 
PAPEL DE LA LINFADENECTOMÍA EN EL ADENOCARCINOMA DE ENDOMETRIO CORONADO MARTÍN, P. J.Departamento de Obstetricia y Ginecología.
Hospital Clínico San Carlos de Madrid.
FASERO LAIZ, M.Servicio de Obstetricia y Ginecología.
Hospital de la Zarzuela. Madrid

BIBLIOGRAFÍA

  1. Sorosky JI. Endometrial cancer. Obstet Gynecol. 2008 Feb;111(2 Pt 1):436-47
  2. Coronado PJ, Vidart JA, Lopez JA, Fasero M, Furio-Bacete V, Magrina J, Escudero M. p53 overexpression is better predictor of recurrence than her-2/neu overexpression in endometrial carcinoma. Eur J Obstet Gynecol Reprod Biol. 2001 Sep;98(1):103-8
  3. Coronado PJ, Fasero M, Vidart JA, Puerta J, Magrina J, Furio-Bacete V, Escudero M. A comparison of epithelial membrane antigen overexpression in benign and malignant endometrium. Gynecol Oncol. 2001 Sep;82(3):483-8
  4. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer 1987; 60: 2035-2041.
  5. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182: 1506-19
  6. Larson DM, Johnson K, Olson KA.Pelvic and para-aortic lymphadenectomy for surgical staging ofendometrial cancer: Morbidity and mortality.Obstet Gynecol 1992;79: 998 1001.
  7. Fanning S, Firestein S. Prospective evaluation of the morbidity of complete lymphadenectomy in endometrial cancer. Int J Gynecol Cancer 1998; 8: 270-273.
  8. Chuang L, Burke TW, Tornos C, Marino BD, Mitchell MF, Tortolero-Luna G, Levenback C, Morris M, Gershenson DM.Staging laparotomy for endometrial carcinoma: Assessmentof retroperitoneal lymph nodes.Gynecol Oncol 1995;58: 189 93.
  9. Franchi M, Ghezzi F, Riva C, Miglierina M, Buttarelli M, Bolis P. Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J Surg Oncol. 2001;78: 232-7.
  10. Moore DH, Fowler W, Walton L, Droegemueller W. Morbidity of lymph node sampling in cancers of the uterine corpus and cervix. Obstet Gynaecol 1989; 74: 180-4.
  11. Nunns D, Williamson K, Swaney L, Davy M. The morbidity of surgery and adyuvant radiotherapy in the management of endometrial carcinoma. Int J Gynecol Cancer 2000;10: 233-238.
  12. Babilonti L, Pietro G, Fianza A, Beretta P, Franchi M. Complications of pelvic lymphadenectomy in patients with endometrial adenocarcinoma. Eur J Gynaecol Onc 1989; 10:131-3.
  13. Kalogiannidis I, Lambrechts S, Amant F, Neven P, Van Gorp T, Vergote I. Laparoscopy-assisted vaginal hysterectomy compared with abdominal hysterectomy in clinical stage I endometrial cancer: safety, recurrence, and long-term outcome. Am J Obst Gynecol 2007;196:248.e1-248.e8
  14. Magrina JF, Kho RM, Weaver AL, Montero RP, Magtibay PM. Robotic radical hysterectomy: comparison with laparoscopy and laparotomy. Gynecol Oncol. 2008 Apr;109(1):86-91.
  15. Benedet JL et al. Staging classifications and clinical practice guidelines of gynaecologic cancers. Inter J Gynecol Obst. 2000; 70: 207-312
  16. Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR, Oram DH, Jacobs IJ, Shepherd JH, Reznek RH. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cáncer. J Clin Oncol 2005.
  17. Cabrita S, Rodrigues H, Abreu R, Martins M, Teixeira L, Marques C, Mota F, de Oliveira CF. Magnetic resonance imaging in the preoperative staging of endometrial carcinoma. Eur J Gynaecol Oncol. 2008;29(2):135-7
  18. Yamashita Y, Mizutani H, Torashima M, Takahashi M, Miyazaki K, Okamura H, Ushijima H, Ohtake H, Tokunaga T. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR Am J Roentgenol. 1993 Sep;161(3):595-9.
  19. Traen K, Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta Obstet Gynecol Scand. 2007;86(6):739-41
  20. Zuurendonk LD, Smit RA, Mol BW, Feijen HW, de Graaff J, Sykora D, de Winter KA, vd Wurff A, Snijders MP, Kruitwagen RF. Routine pelvic lymphadenectomy in apparently early stage endometrial cancer. Eur J Surg Oncol. 2006 May;32(4):450-4
  21. Mariani A, Dowdy SC, Cliby WA, Haddock MG, Keeney GL, Lesnick TG, Podratz KC. Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients Gynecol Oncol. 2006 May;101(2):200-8.
  22. Lutman CV, Havrilesky LJ, Cragun JM, Secord AA, Calingaert B, Berchuck A, Clarke-Pearson DL, Soper JT. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol Oncol. 2006 Jul;102(1):92-7
  23. Mariani A, Dowdy SC, Cliby WA, Gostout BS, Jones MB, Wilson TO, Podratz KC.  Prospective assessment of lymphatic dissemination in endometrial cancer: A paradigm shift in surgical staging. Gynecol Oncol. 2008 Feb 26 [Epub ahead of print]
  24. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F, Conner W. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol 1995; 56: 29-33.
  25. Larson DM, Brosic SK, Krawisz BR. Surgery without radiotherapy for primary treatment of endometrial cáncer. Obstet Gynecol 1998; 91: 355-359.
  26. Fanning J, Nanvali PJ, Hilgers RD. Surgical staging and high dose rate brachytherapy for endometrial cáncer: Limiting external radiotherapy to node-positive tumor. Obstet Gynecol 1996; 87: 1041-1044.
  27. Mohan DS, Samuels MA, Mostafa AS, et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol 1998; 70: 165-171.
  28. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and para-aortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997; 64:411-7.
  29. Barnes MN, Kilgore LC. Complete surgical staging of early endometrial adenocarcinoma: optimizing patient outcomes. Semin Radiat Oncol 2000;10:3-7.
  30. Havrilesky LJ, Cragun JM. Resection lymph nodes metastases influences survival in stage IIIC carcinoma of endometrial cancer. Gynecol Oncol 2005(Dec);99:689-95.
  31. Lin LL, Mutch DG, Rader JS, Powell MA, Grigsby PW. External radiotherapy versus vaginal brachytherapy for patients with intermediate risk endometrial cancer. Gynecol Oncol. 2007;106 : 215-20.
  32. Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Arch Gynecol Obstet 2006; 274: 91-6.
  33. Naumann RW, Coleman RL. The use of adjuvant radiation therapy in early endometrial cancer by members of the Society of Gynecologic Oncologists in 2005. Gynecol Oncol. 2007; 105 :7-12.
  34. Kong A, Johnson N, Cornes P, Simera I, Collingwood M, Williams C, Kitchener H. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev. 2007 Apr 18;(2):CD003916.
  35. Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, Wárlám-Rodenhuis CC, De Winter KA, Lutgens LC, van den Bergh AC, van der Steen-Banasik E, Beerman H, van Lent M; PORTEC Study Group. The Postoperative Radiation Therapy in Endometrial Carcinoma. The morbidity of treatment for patients with stage I endometrial cancer: results from a randomized trial. Int J Radiat Oncol Biol Phys 2001;51:1246-55.
  36. Kitchener H, Redman CW, Swart AM, Amos CL, ASTEC Study Group. ASTEC-A Study in the Treatment of Endometrial Cancer: a randomised trial of lymphadenectomy in the treatment of endometrial cancer. Proc Soc Gynecol Oncol Abstr. 2006; 45.
  37. Orton J. Adjuvant external beam radiotherapy (EBRT) in the treatment of endometrial cancer: results of the randomized MRC ASTEC and NCIC CTG EN.5 trials. Communication presented in ASCO. Chicago, June 2007
  38. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007 Aug;106(2):282-8
  39. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, Kapp DS. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006 Oct 15;107(8):1823-30

 
 

Página desarrollada por Edicorp. Webmaster:[email protected]